• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein.

作者信息

Chew D P, Bhatt D L, Robbins M A, Mukherjee D, Roffi M, Schneider J P, Topol E J, Ellis S G

机构信息

Department of Cardiology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.

出版信息

Am J Cardiol. 2001 Sep 15;88(6):672-4. doi: 10.1016/s0002-9149(01)01813-6.

DOI:10.1016/s0002-9149(01)01813-6
PMID:11564394
Abstract
摘要

相似文献

1
Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein.经皮冠状动脉介入治疗前在阿司匹林基础上加用氯吡格雷对C反应蛋白相关风险的影响。
Am J Cardiol. 2001 Sep 15;88(6):672-4. doi: 10.1016/s0002-9149(01)01813-6.
2
Clopidogrel with aspirin is the optimal antiplatelet regimen for intracoronary stenting.
J Thromb Thrombolysis. 1999 Jun;7(3):227-31. doi: 10.1023/a:1008981408216.
3
Aspirin and ticlopidine after routine coronary stenting: the gold standard as of 1999.常规冠状动脉支架置入术后使用阿司匹林和噻氯匹定：1999年的金标准。
J Thromb Thrombolysis. 1999 Jun;7(3):233-9. doi: 10.1023/a:1008922925054.
4
Clopidogrel and percutaneous coronary interventions.氯吡格雷与经皮冠状动脉介入治疗
JAMA. 2003 Apr 16;289(15):1926; author reply 1926-7. doi: 10.1001/jama.289.15.1926-a.
5
Clopidogrel and percutaneous coronary interventions.氯吡格雷与经皮冠状动脉介入治疗
JAMA. 2003 Apr 16;289(15):1925-6; author reply 1926-7. doi: 10.1001/jama.289.15.1925-b.
6
Clopidogrel and percutaneous coronary interventions.氯吡格雷与经皮冠状动脉介入治疗
JAMA. 2003 Apr 16;289(15):1926; author reply 1926-7. doi: 10.1001/jama.289.15.1926-b.
7
Clopidogrel and percutaneous coronary interventions.氯吡格雷与经皮冠状动脉介入治疗
JAMA. 2003 Apr 16;289(15):1925; author reply 1926-7. doi: 10.1001/jama.289.15.1925-a.
8
Clopidogrel and percutaneous coronary interventions.氯吡格雷与经皮冠状动脉介入治疗
JAMA. 2003 Apr 16;289(15):1926; author reply 1926-7. doi: 10.1001/jama.289.15.1926-c.
9
Effectiveness of clopidogrel versus aspirin in preventing acute myocardial infarction in patients with symptomatic atherothrombosis (CAPRIE trial).
Am J Cardiol. 2002 Oct 1;90(7):760-2. doi: 10.1016/s0002-9149(02)02606-1.
10
Effectiveness of aspirin and clopidogrel combination therapy in coronary stenting.
Am J Cardiol. 1999 Sep 15;84(6):726-8, A8. doi: 10.1016/s0002-9149(99)00420-8.

引用本文的文献

1
The role of P2Y receptor in ischemic stroke of atherosclerotic origin.P2Y 受体在动脉粥样硬化性缺血性卒中中的作用。
Cell Mol Life Sci. 2019 Jan;76(2):341-354. doi: 10.1007/s00018-018-2937-2. Epub 2018 Oct 9.
2
Effects of clopidogrel therapy on oxidative stress, inflammation, vascular function, and progenitor cells in stable coronary artery disease.氯吡格雷治疗对稳定型冠状动脉疾病患者氧化应激、炎症、血管功能及祖细胞的影响。
J Cardiovasc Pharmacol. 2014 Apr;63(4):369-74. doi: 10.1097/FJC.0000000000000057.
3
Pharmacology of the new P2Y12 receptor inhibitors: insights on pharmacokinetic and pharmacodynamic properties.
新型 P2Y12 受体抑制剂的药理学：对药代动力学和药效动力学特性的深入了解。
Drugs. 2013 Oct;73(15):1681-709. doi: 10.1007/s40265-013-0126-z.
4
Beyond thrombosis: the versatile platelet in critical illness.超越血栓形成：危重病中多功能的血小板。
Chest. 2011 Mar;139(3):658-668. doi: 10.1378/chest.10-1971.
5
PROCLAIM: pilot study to examine the effects of clopidogrel on inflammatory markers in patients with metabolic syndrome receiving low-dose aspirin.PROCLAIM：一项初步研究，旨在考察氯吡格雷对接受低剂量阿司匹林治疗的代谢综合征患者炎症标志物的影响。
Tex Heart Inst J. 2009;36(6):530-9.
6
Efficacy of clopidrogel on reperfusion and high-sensitivity C-reactive protein in patients with acute myocardial infarction.氯吡格雷对急性心肌梗死患者再灌注及高敏C反应蛋白的疗效
Mediators Inflamm. 2009;2009:932515. doi: 10.1155/2009/932515. Epub 2009 Apr 12.
7
New evidences for C-reactive protein (CRP) deposits in the arterial intima as a cardiovascular risk factor.动脉内膜中C反应蛋白（CRP）沉积作为心血管危险因素的新证据。
Clin Interv Aging. 2008;3(2):341-9. doi: 10.2147/cia.s2706.
8
Beyond platelet inhibition: potential pleiotropic effects of ADP-receptor antagonists.超越血小板抑制作用：ADP受体拮抗剂的潜在多效性作用
J Thromb Thrombolysis. 2009 Apr;27(3):300-6. doi: 10.1007/s11239-008-0221-2. Epub 2008 Apr 9.
9
Determining the efficacy of antiplatelet therapies for the individual: lessons from clinical trials.
J Thromb Thrombolysis. 2008 Aug;26(1):8-13. doi: 10.1007/s11239-007-0160-3. Epub 2007 Nov 1.
10
Relation between impaired antiplatelet response to clopidogrel and possible pleiotropic effects.氯吡格雷抗血小板反应受损与可能的多效性作用之间的关系。
J Thromb Thrombolysis. 2007 Dec;24(3):301-5. doi: 10.1007/s11239-007-0026-8. Epub 2007 Apr 3.